Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Japanese patients with rheumatoid arthritis
jRCTs031180050Completed
- Sponsor
- Sanofi
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of hydroxychloroquine in rheumatoid arthritis (RA) (2 arms), sponsored by Sanofi. Primary endpoint: ACR20 response at week 24. Started Dec 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCTs031180050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180050.